A 28-year-old female athlete undergoes intense anaerobic exercise. Simultaneously, a 28-year-old male with cirrhosis presents with elevated blood lactate despite rest. Which feature best distinguishes lactate metabolism in the exercising athlete from that in the cirrhotic patient?

Explanation

## Distinguishing Lactate Metabolism: Exercise vs. Cirrhosis ### The Question's Core Logic **Key Point:** The stem asks which feature **best distinguishes** lactate metabolism in the **exercising athlete** from that in the **cirrhotic patient**. The correct answer must describe a feature that is **characteristic of the athlete's physiology** and **contrasts** with the cirrhotic patient's pathology. ### Why Option C is Correct **High-Yield:** In the exercising athlete, the **Cori cycle** operates normally: 1. Skeletal muscle undergoes anaerobic glycolysis → **lactate produced** 2. Lactate enters the bloodstream and is transported to the liver 3. Hepatocytes take up lactate via monocarboxylate transporters (MCT1/2) 4. Lactate → pyruvate (lactate dehydrogenase, LDH) 5. Pyruvate → glucose via **gluconeogenesis** 6. Glucose is released back to muscle for energy This is the defining feature of the **athlete's** lactate metabolism — lactate is produced in muscle and efficiently cleared by the liver via gluconeogenesis. This is the Cori cycle functioning normally. ### Why Option D is Incorrect as the "Distinguishing" Feature Option D states: *"Lactate accumulates because hepatic uptake is impaired."* This describes the **cirrhotic patient's** pathology, **not** the exercising athlete's physiology. The question asks what distinguishes the **athlete** from the cirrhotic patient. Option D characterizes the cirrhotic patient, not the athlete — it is the wrong subject of the comparison. ### Why the Other Options Are Wrong | Option | Problem | |--------|---------| | **A** | Describes the cirrhotic patient (elevated lactate after exercise cessation), not the athlete | | **B** | Partially true (lactate → pyruvate does occur in hepatocyte mitochondria), but this is a shared mechanism, not a distinguishing feature of the athlete specifically | | **D** | Describes cirrhosis pathology, not the athlete's physiology | ### Comparison Table | Feature | Exercising Athlete | Cirrhotic Patient | |---------|-------------------|-------------------| | **Lactate source** | Muscle (anaerobic glycolysis) | Muscle + impaired clearance | | **Hepatic uptake** | Normal/intact | Impaired/reduced | | **Gluconeogenesis** | Functional — converts lactate → glucose | Reduced/impaired | | **Blood lactate trend** | Normalizes quickly post-exercise | Remains elevated at rest | | **Cori cycle** | Fully operational | Disrupted | **Clinical Pearl:** In cirrhosis, loss of functional hepatocytes, reduced LDH activity, decreased gluconeogenic capacity, and portal-systemic shunting all contribute to lactate accumulation. Lactate >4 mmol/L in cirrhosis predicts poor outcomes. **Warning:** Option C is true for the athlete and contrasts with the cirrhotic patient (who cannot efficiently perform hepatic gluconeogenesis from lactate). Option D, while factually true about cirrhosis, describes the cirrhotic patient — not the distinguishing feature of the athlete. **Mnemonic:** **CORI** — Clearance Of lactate Requires Intact hepatic gluconeogenesis [cite: Harper's Illustrated Biochemistry 31e, Ch 19 — Gluconeogenesis and the Cori Cycle; KD Tripathi 8e Ch 6]